Research Article
Antibiotic Resistance of Enteric Bacteria in HIV-Infected Patients at the Banka Ad-Lucem Hospital, West Region of Cameroon
Table 4
Antibiotic resistance profile of bacterial isolates from HIV-seropositive and HIV-seronegative patients.
| | Antibiotics | | Enterobacter aerogenes | Klebsiella pneumoniae | Escherichia coli | Shigella sp. | Salmonella sp. | | HIV+ n (%) | HIV− n (%) | HIV+ n (%) | HIV− n (%) | HIV+ n (%) | HIV− n (%) | HIV+ n (%) | HIV− n (%) | HIV+ n (%) | HIV− n (%) |
| | IPM | R | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | | I | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | | S | 22 (100) | 15 (100.00) | 37 (100) | 15 (100.00) | 18 (100) | 6 (100.00) | 15 (100) | 7 (100.00) | 5 (100) | 1 (100.00) |
| | AMC | R | 13 (59.09) | 12 (80.00) | 17 (45.95) | 6 (40.00) | 6 (33.33) | 3 (50.00) | 5 (33.33) | 6 (85.71) | 2 (40.00) | 0 (0.00) | | I | 6 (27.27) | 1 (6.67) | 9 (24.32) | 5 (33.33) | 8 (44.44) | 2 (33.33) | 4 (26.67) | 0 (0.00) | 2 (40.00) | 1 (100.00) | | S | 3 (13.64) | 2 (13.33) | 11 (29.73) | 4 (26.67) | 4 (22.22) | 1 (16.67) | 6 (40.00) | 1 (14.29) | 1 (20.00) | 0 (0.00) |
| | NOR | R | 0 (0.00) | 1 (6.67) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 1 (14.29) | 0 (0.00) | 0 (0.00) | | I | 2 (9.09) | 1 (6.67) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.000 | 0 (0.00) | 1 (14.29) | 0 (0.00) | 0 (0.00) | | S | 20 (90.91) | 13 (86.67) | 37 (100.00) | 15 (100.00) | 18 (100.00) | 6 (100.000 | 15 (100.00) | 5 (71.43) | 5 (100.00) | 1 (100.00) |
| | CIP | R | 1 (4.55) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | | I | 2 (9.09) | 0 (0.00) | 1 (2.70) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | | S | 19 (86.36) | 15 (100.00) | 36 (97.30) | 15 (100.00) | 18 (100.00) | 6 (100.00) | 15 (100.00) | 7 (100.00) | 5 (100.00) | 1 (100.00) |
| | CFM | R | 4 (18.18) | 12 (80.00) | 10 (27.03) | 2 (13.33) | 6 (33.33) | 1 (16.67) | 2 (13.33) | 4 (57.14) | 1 (20.00) | 1 (100.00) | | I | 1 (4.55) | 1 (6.67) | 4 (10.81) | 1 (6.67) | 1 (5.56) | 1 (16.67) | 3 (20.00) | 1 (14.29) | 2 (40.00) | 0 (0.00) | | S | 17 (77.27) | 2 (13.33) | 23 (62.16) | 12 (80.00) | 11 (61.11) | 4 (66.67) | 10 (66.67) | 2 (28.57 | 2 (40.00) | 0 (0.00) |
| | CRO | R | 4 (18.18) | 10 (66.67) | 10 (27.03) | 4 (26.67) | 4 (22.22) | 2 (33.33) | 3 (20.00) | 4 (57.14) | 1 (20.00) | 0 (0.00) | | I | 9 (40.91) | 1 (6.67) | 12 (32.43) | 5 (33.33) | 4 (22.22) | 0 (0.00) | 4 (26.67) | 2 (28.57) | 1 (20.00) | 0 (0.00) | | S | 9 (40.91) | 4 (26.67) | 15 (40.54) | 6 (40.00) | 10 (55.56) | 4 (66.67) | 8 (53.33) | 1 (14.29) | 3 (60.00) | 1 (100.00) |
| | AMK | R | 2 (9.09) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | | I | 8 (36.36) | 8 (53.33) | 18 (48.65) | 12 (80.00) | 8 (44.44) | 3 (50.00) | 10 (66.67) | 4 (57.14) | 4 (80.00) | 0 (0.00) | | S | 12 (54.55) | 7 (46.67) | 19 (51.35) | 3 (20.00) | 10 (55.56) | 3 (50.00) | 5 (33.33) | 3 (42.86) | 1 (20.00) | 1 (100.00) |
| | CHL | R | 5 (22.73) | 8 (53.33) | 2 (5.41) | 1 (6.67) | 3 (16.67) | 0 (0.00) | 0 (0.00) | 2 (28.57) | 1 (20.00) | 0 (0.00) | | I | 2 (9.09) | 1 (6.67) | 4 (10.81) | 3 (20.00) | 0 (0.00) | 0 (0.00) | 4 (26.67) | 2 (28.57) | 2 (40.00) | 1 (100.00) | | S | 15 (68.18) | 6 (40.00) | 31 (83.78) | 11 (73.33) | 15 (83.33) | 6 (100.000) | 11 (73.33) | 3 (42.86) | 2 (40.00) | 0 (0.00) |
|
|
Imipeneme, IMP; amoxicillin/clavuranic acid, AMC; norfloxacin, NOR, ciprofloxacin, CIP; cefixime, CFM; ceftriaxon, CRO; amikacin, AMK, chloramphenicol, CHL.
|
